Advertisement
Product › Details
drug development
Next higher product group | drug discovery | |
Record changed: 2024-10-12 |
Advertisement
More documents for drug development
- [1] Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA....
- [2] Boehringer Ingelheim. (10/9/24). "Press Release: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment". Ingelheim & South San Francisco, CA....
- [3] Roche. (9/10/24). "Press Release: Roche Opens Pharma Research and Development Center in Basel to Accelerate Scientific Innovation". Basel....
- [4] Novartis AG. (8/22/24). "Press Release: Novartis Employs Creative Deal Structure to Establish Borealis Biosciences – Divests Legacy Chinook Site, Invests to Form New Company and Engages in R&D collaboration"....
- [5] Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai....
- [6] 65LAB. (7/29/24). "Press Release: 65LAB and Duke-NUS Award US$1.85 Million to Combat Chronic Inflammation". Singapore....
- [7] Confo Therapeutics N.V.. (7/26/24). "Press Release: Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Development". Ghent....
- [8] Haya Therapeutics SA. (7/18/24). "Press Release: Haya Therapeutics Appoints Former Roche Global Head of Operations Eric Adam, Ph.D. as Chief Operating Officer". Lausanne & San Diego, CA....
- [9] Full-Life Technologies. (7/3/24). "Press Release: Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer". Heidelberg....
- [10] Mission Therapeutics Ltd.. (7/2/24). "Press Release: Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top